ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: May 7, 2025
1Q 2025 Total Revenue of $114.8 Million (Adjusted Total Revenue(1) of $118.6 Million), a 40% YoY Increase
Read more at globenewswire.com
